RENAL CELL CARCINOMA METASTATIC
Clinical trials for RENAL CELL CARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney cancer surgery showdown: immunotherapy first, then knife or not?
Disease control Recruiting nowThis study looks at whether removing the kidney tumor after initial immunotherapy can help people with advanced kidney cancer that has spread. About 400 participants will either have surgery or not after starting treatment. The goal is to see which approach leads to longer surviv…
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Phase: NA • Sponsor: Niels Fristrup • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Radiation boost may extend life in kidney cancer that has spread
Disease control Recruiting nowThis study tests whether adding precise, high-dose radiation (SBRT) to standard drug therapy can help people with kidney cancer that has spread to up to 5 spots live longer without the cancer growing. About 252 adults with kidney cancer will be randomly assigned to receive either…
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New antibody targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new antibody drug, OM-RCA-01, in people with advanced cancers that have a specific protein called FGFR1. The goal is to see if the drug is safe and can slow tumor growth. About 58 adults with kidney, lung, prostate, breast, or head & neck cancer will receive th…
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Kidney Cancer Research Bureau • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
Blood tests could make kidney cancer drugs safer and more effective
Knowledge-focused Recruiting nowThis study tracks drug levels in the blood of 200 people with advanced kidney cancer to see if monitoring can improve how well the drugs work and reduce side effects. Researchers will also look at how genetics and immune responses affect treatment. No new drugs are being tested—t…
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Sponsor: Niels Fristrup • Aim: Knowledge-focused
Last updated May 17, 2026 11:21 UTC